Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Ribaud

Showing results (61-70 of 134) with videos related to

Pageof 14
Sort By:
Cancer Chemotherapy and Pharmacology|January 1, 1978
Preliminary results of a phase II trial of aclacinomycin in acute leukaemia and lymphosarcoma. An oncostatic anthracyclin that is rarely cardiotoxic and induces no alopeciaG Mathé, M Bayssas, J Gouveia, et al.
Transplantation|January 11, 2001
Cystectomy for severe hemorrhagic cystitis in allogeneic stem cell transplant recipientsL Garderet, H Bittencourt, P Sebe, et al.
Bone Marrow Transplantation|June 1, 1995
Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission: factors predictive of survival, relapse and graft-versus-host diseaseM Moussalem, H Esperou Bourdeau, A Devergie, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 13, 2009
Evaluation of a new 5'-nuclease real-time PCR assay targeting the Toxoplasma gondii AF146527 genomic repeatJ Menotti, Y J-F Garin, P Thulliez, et al.
Cancer Treatment Reports|June 1, 1984
Phase I-II study of aclarubicin for treatment of acute myeloid leukemiaD Machover, J Gastiaburu, M Delgado, et al.
Bone Marrow Transplantation|November 1, 1994
Impact of liver disease and hepatitis infections on allogeneic bone marrow transplantation in Europe: a survey from the European Bone Marrow Transplantation (EBMT) Group--Infectious Diseases Working PartyA Locasciulli, A Alberti, R de Bock, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 9, 2009
High rate of breakthrough invasive aspergillosis among patients receiving caspofungin for persistent fever and neutropeniaM Lafaurie, J Lapalu, E Raffoux, et al.
The Journal of Antimicrobial Chemotherapy|August 29, 2015
Prospective pilot study of high-dose (10 mg/kg/day) liposomal amphotericin B (L-AMB) for the initial treatment of mucormycosisF Lanternier, S Poiree, C Elie, et al.
Journal of Medical Economics|December 24, 2010
Cost effectiveness of posaconazole in the prophylaxis of invasive fungal infections in acute leukaemia patients for the French healthcare systemM Michallet, J P Gangneux, A Lafuma, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1980
Vindesine: a new vinca alkaloidM Bayssas, J Gouveia, F de Vassal, et al.
Pageof 14

Showing results (61-70 of 134) with videos related to

Sort By:
Pageof 14
Cancer Chemotherapy and Pharmacology|January 1, 1978
Preliminary results of a phase II trial of aclacinomycin in acute leukaemia and lymphosarcoma. An oncostatic anthracyclin that is rarely cardiotoxic and induces no alopeciaG Mathé, M Bayssas, J Gouveia, et al.
Transplantation|January 11, 2001
Cystectomy for severe hemorrhagic cystitis in allogeneic stem cell transplant recipientsL Garderet, H Bittencourt, P Sebe, et al.
Bone Marrow Transplantation|June 1, 1995
Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission: factors predictive of survival, relapse and graft-versus-host diseaseM Moussalem, H Esperou Bourdeau, A Devergie, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 13, 2009
Evaluation of a new 5'-nuclease real-time PCR assay targeting the Toxoplasma gondii AF146527 genomic repeatJ Menotti, Y J-F Garin, P Thulliez, et al.
Cancer Treatment Reports|June 1, 1984
Phase I-II study of aclarubicin for treatment of acute myeloid leukemiaD Machover, J Gastiaburu, M Delgado, et al.
Bone Marrow Transplantation|November 1, 1994
Impact of liver disease and hepatitis infections on allogeneic bone marrow transplantation in Europe: a survey from the European Bone Marrow Transplantation (EBMT) Group--Infectious Diseases Working PartyA Locasciulli, A Alberti, R de Bock, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 9, 2009
High rate of breakthrough invasive aspergillosis among patients receiving caspofungin for persistent fever and neutropeniaM Lafaurie, J Lapalu, E Raffoux, et al.
The Journal of Antimicrobial Chemotherapy|August 29, 2015
Prospective pilot study of high-dose (10 mg/kg/day) liposomal amphotericin B (L-AMB) for the initial treatment of mucormycosisF Lanternier, S Poiree, C Elie, et al.
Journal of Medical Economics|December 24, 2010
Cost effectiveness of posaconazole in the prophylaxis of invasive fungal infections in acute leukaemia patients for the French healthcare systemM Michallet, J P Gangneux, A Lafuma, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1980
Vindesine: a new vinca alkaloidM Bayssas, J Gouveia, F de Vassal, et al.
Pageof 14